SEQanswers

Go Back   SEQanswers > Events / Conferences



Similar Threads
Thread Thread Starter Forum Replies Last Post
WEBINAR: Analyze RNA-Seq Data to Identify Biological Affects of Zika Virus Infection mgabrielli@partek.com Events / Conferences 0 08-23-2016 01:07 AM
calculating mutation burden per TCGA sample adrian Bioinformatics 0 04-25-2015 02:27 PM
TCGA sample type Zhan yueping Bioinformatics 2 03-30-2015 04:41 PM
Best approach to analyze taxonomic profiling of metagenomes from environmental sample tigerxu Metagenomics 4 10-17-2013 04:03 AM

Reply
 
Thread Tools
Old 03-24-2017, 01:05 PM   #1
kgosche@partek.com
Junior Member
 
Location: St. Louis

Join Date: Aug 2016
Posts: 5
Default Webinar: How one researcher analyze piRNAs from 7,000 TCGA sample

Webinar:
Unique somatic and malignant expression patterns implicate PIWI-interacting RNAs in cancer-type specific biology

April 20, 2:00 p.m. CDT
REGISTER

Presented by:
Victor Martinez, Ph.D.
Biomedical Sciences
British Columbia Cancer Research Centre


___________

PIWI-interacting RNAs (piRNAs) are small (24-32bp) non-coding RNAs with a key role in epigenetic regulation of gene expression and maintenance of genomic stability in germ cells. Recent evidence suggests they are also expressed and functionally active in somatic tissues. Expression of individual piRNAs has been explored in some cancer types; however, their somatic expression patterns are largely uncharted.

To investigate piRNA expression in human tissues, we analyzed 6,260 small non-coding RNAs (sncRNAs) sequence samples from 11 different organs available from The Cancer Genome Atlas. To deduce expression of approximately ~32,000 human piRNAs on each sample, we built a custom small-RNA sequence analysis pipeline supported by the Partek® Flow® platform. This strategy allowed us to analyze one of the biggest cohort of sncRNAs available worldwide, in a time- and cost-effective manner.

We discovered that a small, but significant fraction of the known piRNAs are expressed in somatic tissues, displaying tissue-specific patterns. Moreover, more than 500 piRNAs are expressed in corresponding tumour tissues, largely distinguishing tumour from non-malignant tissues in a cancer-type specific manner. Most expressed piRNAs mapped to known transcripts, contrary to “piRNA clusters” reported in germline cells. We also showed that piRNA expression signatures can delineate clinical features, such as histological subgroups, disease stages, and patient survival.

Here, we provide evidence of somatic, tissue-specific human piRNA expression. Aberrant expression patterns contribute to cancer subtype-specific biology. We discover piRNA-based signatures that identify aggressive tumors and have prognostic value. The unique expression patterns of piRNAs offer an opportunity to better understand cancer-specific biology as well as develop novel prognostic markers for clinical application.

___________

About Victor Martinez
Victor Martinez received his Ph.D. in Biomedical Sciences from the University of Chile, before joining the British Columbia Cancer Research Centre in Vancouver, Canada. He leads several ‘big data’ projects that investigate cancer etiology and tumor biology, with a long-term vision of translating his findings to benefit cancer patients. Dr. Martinez’s publications span multiple disciplines, including cancer biology, genomics, epigenetics, and computational biology. He is internationally recognized for his work on non-coding RNA transcriptome, and has received multiple awards for his contributions to the field of environmental cancer genomics. Currently, he serves on the editorial boards of Scientific Reports and Biomed Research International.
kgosche@partek.com is offline   Reply With Quote
Reply

Tags
cancer, rna, rna sequencing, small rna seq, webinar

Thread Tools

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off




All times are GMT -8. The time now is 07:49 AM.


Powered by vBulletin® Version 3.8.9
Copyright ©2000 - 2019, vBulletin Solutions, Inc.
Single Sign On provided by vBSSO